Previous studies have shown that ALDH+ and CD133+ cells are enriched with ovarian cancer-initiating (stem) cells, and that ALDH and CD133 may be widely used as reliable markers to investigate ovarian cancer stem cell biology8. The gene discussed is LDHA; the disease is ovarian cancer.